| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 897.90M | 898.60M | 872.30M | 799.60M | 401.70M | 515.50M |
| Gross Profit | 166.80M | 489.10M | 435.70M | 335.40M | 74.20M | 160.20M |
| EBITDA | 202.70M | 166.20M | 115.30M | 296.20M | -20.50M | -250.70M |
| Net Income | 44.30M | -18.50M | -9.30M | 137.20M | -127.70M | -359.60M |
Balance Sheet | ||||||
| Total Assets | 2.21B | 2.21B | 2.45B | 2.52B | 2.47B | 2.53B |
| Cash, Cash Equivalents and Short-Term Investments | 32.30M | 45.50M | 29.60M | 30.70M | 35.40M | 42.60M |
| Total Debt | 1.28B | 1.30B | 1.60B | 1.62B | 1.64B | 1.90B |
| Total Liabilities | 1.53B | 1.56B | 1.81B | 1.87B | 2.06B | 2.28B |
| Stockholders Equity | 678.40M | 654.80M | 640.10M | 648.10M | 406.40M | 248.90M |
Cash Flow | ||||||
| Free Cash Flow | 91.60M | 161.20M | 75.90M | -14.60M | -107.70M | 3.30M |
| Operating Cash Flow | 147.10M | 207.40M | 141.20M | 55.50M | -61.10M | 67.00M |
| Investing Cash Flow | 192.60M | 211.90M | -9.80M | -29.10M | 197.70M | 13.90M |
| Financing Cash Flow | -290.30M | -401.40M | -132.60M | -30.90M | -145.10M | -77.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £1.43B | 8.52 | 6.90% | ― | 1.95% | 275.56% | |
73 Outperform | £288.32M | 6.37 | 10.69% | ― | 0.50% | ― | |
70 Neutral | £331.52M | 12.93 | 6.45% | 3.21% | 4.79% | 223.72% | |
69 Neutral | £8.26M | 4.14 | 10.60% | 1.72% | 2.76% | 40.57% | |
64 Neutral | £683.68M | 10.69 | 17.81% | 1.75% | 4.52% | 50.39% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | £440.85M | 49.24 | 1.27% | 3.02% | 24.95% | -16.86% |
Marston’s PLC has reported strong profit growth and exceeded its £50 million recurring free cash flow target for the fiscal year ending 27 September 2025. The company has achieved significant profit growth for the second consecutive year, driven by its market-leading pub operating model and strategic refurbishments. With plans for accelerated capital expenditure in FY2026, Marston’s aims to build on its momentum, reduce debt, and enhance long-term shareholder value. The appointment of Panmure Liberum as a joint corporate broker is expected to broaden its investor base as it continues its strategic program.
The most recent analyst rating on (GB:MARS) stock is a Hold with a £43.00 price target. To see the full list of analyst forecasts on Marston’s stock, see the GB:MARS Stock Forecast page.
Marston’s PLC announced an update on its total voting rights, revealing that it has 660,362,194 ordinary shares admitted to trading, with 25,700,782 held in treasury, resulting in 187,225,116 voting rights. This change is due to the exercise of options under the Company’s 2022 Sharesave Scheme, impacting how shareholders calculate their voting rights and potentially influencing their investment decisions.
The most recent analyst rating on (GB:MARS) stock is a Hold with a £44.00 price target. To see the full list of analyst forecasts on Marston’s stock, see the GB:MARS Stock Forecast page.
Marston’s PLC has announced an update on its total voting rights as of September 1, 2025. The company, which has a total of 660,362,194 ordinary shares admitted to trading, reports that 25,748,858 of these are held in treasury, with their voting rights suspended. The maximum total voting rights for the company’s issued ordinary shares, excluding treasury shares, is now 187,210,934. This change is due to the exercise of options under the company’s 2022 Sharesave Scheme. Shareholders can use these figures to determine their notification requirements under the Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:MARS) stock is a Hold with a £45.00 price target. To see the full list of analyst forecasts on Marston’s stock, see the GB:MARS Stock Forecast page.
Marston’s PLC has announced an update on its total voting rights as of August 1, 2025, indicating a reduction in the number of shares held in treasury due to the exercise of options under its 2022 Sharesave Scheme. This adjustment affects the calculation of voting rights for shareholders, who must now use the updated figures to determine their interest in the company under the Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:MARS) stock is a Buy with a £78.00 price target. To see the full list of analyst forecasts on Marston’s stock, see the GB:MARS Stock Forecast page.